Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Fatih, Selcukbiricik"'
Autor:
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Cakar, Abdallah T. M. Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gumus, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Publikováno v:
Acta Oncologica. 62:381-390
Autor:
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Burcin Cakan Demirel, Omer Acar, Sercan Aksoy, Naziyet Kose Baytemur, Elif Sahin, Devrim Cabuk, Gul Basaran, Semra Paydas, Arzu Yaren, Deniz Can Guven, Atike Pinar Erdogan, Umut Demirci, Alper Yasar, İbrahim Vedat Bayoglu, Mutlu Hizal, Burcu Gulbagci, Nail Paksoy, Sena Ece Davarci, Funda Yilmaz, Ozlem Dogan, Sibel Oyucu Orhan, Erkan Kayikcioglu, Ali Aytac, Merve Keskinkilic, Eda Eylemer Mocan, Olcun Umit Unal, Esra Aydin, Hakan Yucel, Deniz Isik, Onder Eren, Basak Oyan Uluc, Melike Ozcelik, Ilhan Hacibekiroglu, Adnan Aydiner, Hacer Demir, Berna Oksuzoglu, Ebru Cilbir, Erdem Cubukcu, Bulent Cetin, Esin Oktay, Cihan Erol, Sadi Kerem Okutur, Nilgun Yildirim, Ali Alkan, Fatih Selcukbiricik, Asude Aksoy, Yusuf Karakas, Gulhan Ozkanli, Berna Bozkurt Duman, Dincer Aydin, Ozgecan Dulgar, Muhammed Muhiddin Er, Fatih Teker, Tugba Yavuzsen, Musa Baris Aykan, Ali Inal, Yakup Iriagac, Nurhan Onal Kalkan, Murat Keser, Teoman Sakalar, Serkan Menekse, Engin Kut, Burak Bilgin, Muge Karaoglanoglu, Veli Sunar, Ozlem Ozdemir, Nazim Serdar Turhal, Nuri Karadurmus, Bulent Yalcin, Mehmet Ali Nahit Sendur
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4603b0dea982cdc71feb0666817cb5
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
Autor:
Gunay Uludag, Sumru Onal, Serra Arf, Isil Sayman Muslubas, Fatih Selcukbiricik, Aylin Koc Akbay, Nil Molinas Mandel
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 2, Iss C, Pp 4-7 (2016)
Purpose: To describe the effect of rituximab on full-field electroretinography (ERG) in a patient with nonparaneoplastic autoimmune retinopathy (npAIR). Observations: A 58-year-old male patient with visual complaints, positive anti-retinal antibodies
Externí odkaz:
https://doaj.org/article/ffaa41d46aed49aaa738e8fc6ed869fd
Publikováno v:
Journal of Oncological Sciences, Vol 1, Iss C, Pp 25-30 (2016)
Externí odkaz:
https://doaj.org/article/dffbd6c4b311434b86f8fd6c8e99235f
Autor:
Deniz Tural, Cagatay Arslan, Fatih Selcukbiricik, Omer Fatih Olmez, Emre Akar, Mustafa Erman, Yüksel Ürün, Dilek Erdem, Nuri Karadurmus, Saadettin Kilickap
This 5-year analysis of real-world data confirms the durable response and long-term survival with ICTs in a broader range of patients with metastatic urothelial carcinoma. After 24 months, PFS and OS curves remained nearly flat. The safety profile wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8485e29d30f33b7a367a23c94a9c85a7
https://hdl.handle.net/20.500.12511/11178
https://hdl.handle.net/20.500.12511/11178
Autor:
Saadettin Kilickap, Ahmet Taner Sümbül, Hasan Şenol Coşkun, Deniz Tural, Ömer Fatih Ölmez, Fatih Selcukbiricik, Mustafa Erman, Mehmet Artac
Publikováno v:
International Journal of Clinical Oncology
Background: atezolizumab (ATZ) has demonstrated antitumor activity in previous studies in patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of ATZ was modest. Therefore, finding biologic or clinical biomarke
Autor:
Şeyma İnciser Paşalak, Fatih Selcukbiricik, Yasemin Aydin, Ezgi Bilmiç, Gözde Öz, Memnun Seven, Gulcan Bagcivan
Publikováno v:
Supportive Care in Cancer. 30:749-756
To identify cancer patients’ palliative care needs with problem burden, problem intensity, and felt needs related to these problems while receiving cancer treatment. This is a descriptive survey study conducted at a tertiary hospital with no pallia
Autor:
Mehmet Kanbay, Abdullah Burak Yildiz, Dimitrie Siriopol, Sezan Vehbi, Nuri Baris Hasbal, Yavuz E. Kesgin, Melisa Celayir, Fatih Selcukbiricik, Adrian Covic, Mark A. Perazella
Publikováno v:
International urology and nephrology.
Immunotherapy with immune checkpoint inhibitors (ICPi) may cause acute kidney injury (AKI) and their use is increasing.This is a single-center retrospective cohort study of patients receiving ICPi drugs for solid organ malignancies. ICPi-related AKI,
Autor:
Murat Ayhan, Ahmet Sarici, Seher Yildiz Tacar, Kayhan Erturk, Ilkay Gulturk, Fatih Selcukbiricik, Deniz Tural, Mesut Yilmaz
Publikováno v:
Melanoma Research. 31:449-455
Systemic treatment options with proven efficacy for the treatment of metastatic uveal melanoma are limited. In this study, we aimed to evaluate the efficacy of nivolumab in metastatic uveal melanoma patients. In our multi-center study, the files of p
Autor:
Düriye Sıla Karagöz Özen, Mehmet Akif Öztürk, Fatih Selcukbiricik, Sinem Nihal Esatoglu, Zeynep Hande Turna, Pınar Beyaz, Sergülen Dervisoglu, Mustafa Özgüroglu
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 224-228 (2013)
Primary cardiac osteosarcomas are uncommon tumors. They have an aggressive biology and hence poor prognosis. This report describes a 23-year-old male patient who was referred to our hospital with chest pain. Echocardiography showed a left atrial mass
Externí odkaz:
https://doaj.org/article/b0d1251aed06478c96f912fa1c9da437